Why Viking Therapeutics Stock Topped the Market Today

An analyst waxed bullish on the company's leading pipeline program. Although Viking Therapeutics (VKTX 2.73%) is a busy company, on Monday its stock moved because of external news. A pundit reiterated his bullish take on the clinical-stage biotech, boosting sentiment on its shares and sending them nearly 3% higher in price. That was more than good enough to top the rising S&P 500 index, which closed the trading session up by 0.4%. An instant competitor Like many investors, Morgan Stanley analyst Michael Ulz ...